Atezolizumab Versus Atezolizumab Plus Bevacizumab as First Line in NSCLC Patients (BEAT)
Clinical trial NCT03896074 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03896074
- Sponsor
- Fondazione Ricerca Traslazionale
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-03-02
- Primary completion
- 2027-05-01
- Enrollment
- 206
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.